New antibody combo shows promise in early cancer trial
Disease control
Ongoing
This early-stage trial tests a new drug called DM919, alone or with pembrolizumab, in 160 adults with advanced solid tumors that have spread or cannot be removed. The main goal is to find a safe and effective dose and see if it can shrink tumors. Participants receive the drug thr…
Phase: PHASE1 • Sponsor: D2M Biotherapeutics Inc. • Aim: Disease control
Last updated May 06, 2026 16:02 UTC